IndiaTickerMarksans Pharma Ltd - 524404 - Announcement Under Regulation 30 (LODR)- UpdatesBSE · exchange filing · pdf
Source filing Company dossier
Marksans Pharma
NSE:MARKSANS · ISIN INE750C01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Marksans Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Archived filing Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Press Release - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Record Date - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Record Date - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Marksans Pharma LimitedNSE · financial results · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Dividend UpdatesBSE · corporate action · pdf
Source filing Marksans Pharma Ltd - 524404 - The Annual General Meeting Of The Marksans Pharma Limited Is Scheduled To Be Held On 27 August 2026.BSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - The Board Fixed 20 August 2026 As The Record Date For Ascertaining The Members Of The Company For Payment Of Dividend.BSE · corporate action · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Date of payment of DividendBSE · corporate action · pdf
Source filing Marksans Pharma Ltd - 524404 - Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Annual General Meeting Related MattersBSE · exchange filing · pdf
Source filing Trading Window - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Updates - Marksans Pharma LimitedNSE · financial results · pdf
Source filing Marksans Pharma Ltd - 524404 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - UpdatesBSE · financial results · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"BSE · corporate action · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement Under Regulation 30 (LODR)- UpdatesBSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Credit Rating- Revision - Marksans Pharma LimitedNSE · credit rating · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Marksans Pharma LimitedNSE · conference call · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Copy of Newspaper Publication - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Marksans Pharma LimitedNSE · conference call · pdf
Source filing Marksans Pharma Ltd - 524404 - DISCLOSURE REGARDING SECOND 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"BSE · corporate action · pdf
Source filing General Updates - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Marksans Pharma LimitedNSE · exchange filing · pdf
Source filing Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Marksans Pharma Ltd - 524404 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing